12:00 AM
Feb 21, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Tolerx preclinical data

In a mouse model of cancer, a murine analog of TRX518 as monotherapy and in combination with chemotherapy prevented the establishment of...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >